Simplex Trading
RPRX icon

Simplex Trading’s Royalty Pharma RPRX Stock Holding History

Simplex Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
76,600
+46,400
+154% +$2.03M ﹤0.01% 1342
2025
Q4 		$1.17M Sell
30,200
-51,700
-63% -$1.97M ﹤0.01% 2476
2025
Q3 		$2.89M Sell
81,900
-73,000
-47% -$2.64M ﹤0.01% 1960
2025
Q2 		$5.58M Sell
154,900
-28,600
-16% -$948K ﹤0.01% 1266
2025
Q1 		$5.71M Buy
183,500
+79,000
+76% +$2.5M ﹤0.01% 1223
2024
Q4 		$2.67M Sell
104,500
-2,700
-3% -$71.6K ﹤0.01% 1957
2024
Q3 		$3.03M Buy
107,200
+1,000
+0.9% +$27.7K ﹤0.01% 1913
2024
Q2 		$2.8M Buy
106,200
+51,400
+94% +$1.42M ﹤0.01% 1909
2024
Q1 		$1.66M Sell
54,800
-13,000
-19% -$383K ﹤0.01% 2594
2023
Q4 		$1.9M Sell
67,800
-24,400
-26% -$671K ﹤0.01% 2401
2023
Q3 		$2.5M Sell
92,200
-66,500
-42% -$1.98M ﹤0.01% 1899
2023
Q2 		$4.88M Sell
158,700
-36,900
-19% -$1.25M ﹤0.01% 1333
2023
Q1 		$7.05M Buy
195,600
+95,700
+96% +$3.55M 0.01% 1088
2022
Q4 		$3.95M Sell
99,900
-33,400
-25% -$1.39M ﹤0.01% 1362
2022
Q3 		$5.36M Sell
133,300
-23,200
-15% -$991K 0.01% 1153
2022
Q2 		$6.58M Buy
156,500
+71,100
+83% +$2.91M 0.01% 997
2022
Q1 		$3.33M Buy
85,400
+24,200
+40% +$950K ﹤0.01% 1604
2021
Q4 		$2.44M Buy
61,200
+29,500
+93% +$1.15M ﹤0.01% 1832
2021
Q3 		$1.34M Sell
31,700
-700
-2% -$27.2K ﹤0.01% 2688
2021
Q2 		$1.33M Buy
32,400
+32,019
+8,404% +$1.36M ﹤0.01% 2722
2021
Q1 		$1.66M Buy
381
+232
+156% +$11K ﹤0.01% 1834
2020
Q4 		$745K Sell
149
-28
-16% -$1.19K ﹤0.01% 2931
2020
Q3 		$744K Buy
177
+174
+5,800% +$7.47K ﹤0.01% 2578
2020
Q2 		$14K Buy
+3
New +$148 ﹤0.01% 6454

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Simplex Trading's RPRX Position: Q1 2026 in Review

Simplex Trading sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 9,109 shares — an estimated $399K sold.

Simplex Trading first reported a position in RPRX in Q2 2020 and held it in 11 quarters. The position peaked at $1.29M in Q3 2023. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Simplex Trading reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,109 Royalty Pharma shares in Q1 2026, an estimated $399K.
  • Simplex Trading first reported a position in Royalty Pharma in Q2 2020 and held it in 11 quarters.
  • Simplex Trading's Royalty Pharma position peaked at $1.29M in Q3 2023.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.